Latest statistics and disclosures from Ulys's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Lexicon Pharmaceuticals, and represent 100.00% of Ulys's stock portfolio.
  • Reduced shares in these 1 stocks: Ceres.
  • Sold out of its positions in Ceres.
  • Ulys was a net seller of stock by $1984.
  • Ulys has $78.08M in assets under management (AUM), growing by 25.92%.

Ulys portfolio companies for September 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Lexicon Pharmaceuticals 100.00 4.32M 18.07 0.00

Past 13F-HR SEC Filings for Ulys

View All Filings